← Back to News · 1 outlet · Story cluster #109331

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

How different outlets framed the same story — bias, verdict, and framing side by side.

🤖 D.R.A.F.T. Summary

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Dis

Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workers VANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp.

Outlets covering this story

Financial Post CENTER

Only one perspective covered this story — no diversity detected

📰

Side-by-Side Outlet Comparison — Starter+

See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.

Unlock with Starter →

See plans